Reuters logo
BRIEF-Helix Biopharma Corp announces licence for worldwide right to anti-CEACAM6 antibody from Government of Canada
February 27, 2017 / 12:42 PM / 7 months ago

BRIEF-Helix Biopharma Corp announces licence for worldwide right to anti-CEACAM6 antibody from Government of Canada

Feb 27 (Reuters) - Helix Biopharma Corp

* Helix Biopharma Corp. Announces licence for worldwide right to anti-CEACAM6 antibody from the Government of Canada Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below